Label reference · Pain & musculoskeletal
Emgality (Galcanezumab-Gnlm) Injection, Solution — label reference
DailyMed · Retrieved 2026-10-13
Emgality is listed in DailyMed as injection, solution. Active ingredient: galcanezumab. This reference records product facts and version 17; the original prescribing information and PDF are linked.
Reference details
- Brand / product name
- EMGALITY
- Generic product name
- galcanezumab-gnlm
- Active ingredient
- galcanezumab
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- SPL author / labeler
- Eli Lilly and Company
- SPL version
- 17
- Published on DailyMed
- 2026-06-18
- SPL effective date
- 2026-06-05
- SPL set ID
- 33a147be-233a-40e8-a55e-e40936e28db0
Product identity
Product name: EMGALITY
Generic name: galcanezumab-gnlm
Active ingredients: galcanezumab
Dosage form: INJECTION, SOLUTION
Route: SUBCUTANEOUS
Label version
DailyMed published this record on 2026-06-18. SPL version: 17. Set ID: 33a147be-233a-40e8-a55e-e40936e28db0. The SPL effective date is 2026-06-05.
Original prescribing information
Open the original DailyMed label or PDF below for indications, contraindications, dosing instructions, interactions and warnings. This page contains factual product metadata, not the full prescribing information.
Sources and reuse
- Original DailyMed label
- Original label PDF
- Official SPL XML
- Factual label metadata; original label linked
Bibliographic or product metadata. Read the original source for the complete document.
Source date: 2026-06-18. Retrieved: 2026-10-13. Text has been organized for reading; this import has not been independently reviewed by a clinician. It is not individualized medical advice.